Cancer management includes surveillance of patients after treatment. Such programs become increasingly important since chances of survival after cancer treatment and, thus, disease-free survival rates are continuing to increase. Surveillance programs are also time-consuming and, in addition, a very expensive component of clinical activity since frequent testing is often involved. The choice of a surveillance program is complex and should ideally consider aspects of survival, quality of life, the burden of surveillance tests, and financial costs. As for all clinical decisions, the choice involves a condition of uncertainty. This uncertainty originates from relationships between diagnostic information and the presence of disease, uncertainty about the effects of early treatment, and ambiguity in clinical information.

Additional Metadata
Keywords Analysis, CEA, Decision node, Models, Surveillance strategies
Persistent URL dx.doi.org/10.1007/978-1-60327-969-7_3, hdl.handle.net/1765/101775
Rights No subscription
Citation
van Kessel, K.E.M, Geurts, S.M.E. (Sandra M.E.), Verbeek, A.L.M, & Steyerberg, E.W. (2013). Using decision analysis to model cancer surveillance. In Patient Surveillance After Cancer Treatment (pp. 15–29). doi:10.1007/978-1-60327-969-7_3